Editas Medicine, Inc. Common Stock vs. Repligen Corp
Editas Medicine, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| EDIT | RGEN | |
|---|---|---|
| Market Cap | $399.31 million | $10.98 billion |
RGEN leads on 1 of 1 size & scale factors.
Risk & Sentiment
| EDIT | RGEN | |
|---|---|---|
| Short Interest | 4.06% | 7.13% |
EDIT leads on 1 of 1 risk & sentiment factors.
Dig deeper: EDIT overview, EDIT financials, RGEN overview, RGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.